SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)

CUSIP: P8696W104

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / Common Shares, par value US$0.001 per share
Shares outstanding
71,872,133
Total 13F shares
3,626,233
Share change
+58,374
Total reported value
$22,285,000
Price per share
$6.47
Number of holders
16
Value change
+$420,812
Number of buys
4
Number of sells
1

Sponsored

Quarterly Holders Quick Answers

What is CUSIP P8696W104?
CUSIP P8696W104 identifies SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ORBIMED ADVISORS LLC
13F
Company
4%
2,839,500
 $16,611,000 — 30 Sep 2019
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
3.3%
2,375,841
 $15,372,000 — 30 Sep 2019
13F
Neumann Advisory Hong Kong Ltd
13F
Company
0.44%
315,586
 $2,042,000 — 30 Sep 2019
13F
STATE STREET CORP
13F
Company
0.22%
160,875
 $1,041,000 — 30 Sep 2019
13F
Yorktown Management & Research Co Inc
13F
Company
0.1%
74,893
 $485,000 — 30 Sep 2019
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.1%
68,732
 $445,000 — 30 Sep 2019
13F
Skandinaviska Enskilda Banken AB (publ)
13F
Company
0.06%
40,000
 $259,000 — 30 Sep 2019
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.04%
27,717
 $179,000 — 30 Sep 2019
13F
Freedom Investment Management, Inc.
13F
Company
0.03%
20,727
 $134,000 — 30 Sep 2019
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.02%
16,430
 $106,000 — 30 Sep 2019
13F
NORTHERN TRUST CORP
13F
Company
0.03%
22,374
 $55,000 — 30 Sep 2019
13F
MORGAN STANLEY
13F
Company
0%
1,400
 $9,000 — 30 Sep 2019
13F
GROUP ONE TRADING LLC
13F
Company
0%
412
 $3,000 — 30 Sep 2019
13F
Financial Gravity Asset Management, Inc.
13F
Company
0%
183
 $1,000 — 30 Sep 2019
13F

Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) as of Q4 2019

As of 31 Dec 2019, SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,626,233 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Neumann Advisory Hong Kong Ltd, STATE STREET CORP, Yorktown Management & Research Co Inc, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, Skandinaviska Enskilda Banken AB (publ), GEODE CAPITAL MANAGEMENT, LLC, Navellier & Associates Inc, CIBC Private Wealth Group, LLC, and Eqis Capital Management, Inc.. This page lists 16 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 holders
14
Q4 2019 holders
16
Holder diff
2
Investor Q3 2019 Shares Q4 2019 Shares Share Diff Share Chg % Q3 2019 Value $ Q4 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored